Twitxy Saved

Simon Shen

@twinsmc18

Assistant Professor @WashUCardiology ||Study vascular biology and disease using animals, iPSCs, CRISPR screens, and multiomics
Palo Alto, CA Joined April 2018
1.5K Following 742 Followers 989 Posts

Latest posts 5

Simon Shen @twinsmc18
It is definitely a team effort, and we are proud to provide the cardio-oncology scientific community with an integrative, robust, and generalizable tool to identify causative gene drivers in anti-cancer drug-induced off-target effects on the CVR system @CellStemCell
Chun Verified account @chun_liu_86 Nov 7, 2024
Grateful for the support from @Joseph_C_Wu, @stanleyqilab, all the amazing collaborators @twinsmc18. Also my current department @MCWPhysiology and centers @MCWCancerCenter @CVCatMCW for their ongoing support, enabling us to expand this work to other CVDs and perturb-seq platform
View quoted post on X
0 replies 2 reposts 10 likes 1.1K views View on X
Simon Shen @twinsmc18
this is a good example of leveraging ML&AI to perform drug discovery. Stop selling only fancy concepts, do more like this!
Results from AI-Designed Drug ISM001-055 in Treating Pulmonary Fibrosis

A novel drug named ISM001-055 has shown positive outcomes in clinical trials aimed at treating Idiopathic Pulmonary Fibrosis (IPF).

Developed by Insilico Medicine using generative #AI, the drug targets a specific protein associated with lung fibrosis.
In a Phase IIa trial involving 71 patients, ISM001-055 demonstrated safety and a dose-dependent improvement in lung function, particularly in patients receiving a daily dosage of 60mg.

The drug’s design process exemplifies the application of AI in identifying new therapeutic targets and designing treatment options, indicating potential for future use in other fibrotic conditions as well.

AI in Healthcare #GenAI #TechBio #HealthAI #MedTwitter #MedicalAI
View quoted post on X